Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AbbVie
(NY:
ABBV
)
229.31
+0.82 (+0.36%)
Official Closing Price
Updated: 7:00 PM EST, Jan 2, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
3,336,927
Open
228.74
Bid (Size)
228.20 (100)
Ask (Size)
231.00 (100)
Prev. Close
228.49
Today's Range
225.71 - 230.74
52wk Range
164.39 - 244.81
Shares Outstanding
N/A
Dividend Yield
2.86%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Take Warren Buffett's Advice: Don't Buy Any Stock in 2026 Unless It Passes This Test
↗
Today 5:04 EST
Buffett is no longer at the helm of Berkshire Hathaway. But his investing wisdom remains relevant.
Via
The Motley Fool
Buying This Healthcare Stock Could Make You a Millionaire Retiree
↗
January 03, 2026
It won't happen overnight, but patience will be rewarded.
Via
The Motley Fool
Topics
Intellectual Property
Retirement
Performance
YTD
N/A
N/A
1 Month
+0.3%
+0.3%
3 Month
-0.4%
-0.4%
6 Month
+22.2%
+22.2%
1 Year
+26.5%
+26.5%
More News
Read More
The Evolution of a Healthcare Giant: Abbott Laboratories (ABT) 2026 Stock Feature
January 01, 2026
Via
PredictStreet
Topics
Economy
Lawsuit
World Trade
The Metabolic Squeeze: Big Pharma’s 2025 Defined by $1 Trillion Valuations and Regulatory Reckonings
December 31, 2025
Via
MarketMinute
Topics
Economy
Intellectual Property
Law Enforcement
The Great Rebalancing: As Consumer Confidence Falters, Investors Retreat to the Safety of Large-Cap Value
December 31, 2025
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
AbbVie (ABBV): Buy, Sell, or Hold Post Q3 Earnings?
December 30, 2025
Via
StockStory
Topics
Stocks
Supply Chain
IGSB vs VCSH: Two Approaches to Short-Term Investment-Grade Credit
↗
December 30, 2025
Via
The Motley Fool
Topics
Bonds
ETFs
3 No-Brainer Dividend Stocks to Buy Right Now
↗
December 30, 2025
Via
The Motley Fool
Topics
ETFs
Retirement
The 2026 Income Fortress: Why Big Pharma is the Defensive Play of the New Year
December 30, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Why a New $3 Million Bet on Pathward Stock Signals Confidence in a Bank Posting $7.87 EPS
↗
December 28, 2025
Via
The Motley Fool
Is AbbVie a Buy, Sell, or Hold in 2026?
↗
December 27, 2025
Via
The Motley Fool
Topics
Intellectual Property
The Best Stocks to Invest $50,000 in Right Now
↗
December 27, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
The Vaccine Vanguard: Inside Sanofi’s $2.2 Billion Strategic Bet on Dynavax
December 25, 2025
Via
PredictStreet
Topics
Artificial Intelligence
Economy
Intellectual Property
Top 5 US Healthcare Stocks By Market Value
↗
December 24, 2025
Via
Stocktwits
The Next Big Buyout? Abivax Emerges as a Premier M&A Contender for 2026 Amidst Biotech Consolidation Wave
December 23, 2025
Via
MarketMinute
Topics
Intellectual Property
Want Decades of Passive Income? 3 Stocks to Buy Now and Hold Forever
↗
December 22, 2025
Via
The Motley Fool
Topics
Intellectual Property
3 Dividend Growth Stocks Analysts Are Upgrading for 2026
↗
December 21, 2025
Via
MarketBeat
AbbVie, Merck, Other Top Drugmakers To Lower Prices Of US Drugs In MFN Deal With Trump Administration: Report
↗
December 19, 2025
Via
Stocktwits
Topics
Economy
Government
This Is the 2nd Priciest Stock Market in 155 Years, Which Makes This High-Yield ETF a Genius Buy for 2026
↗
December 19, 2025
Via
The Motley Fool
Topics
Artificial Intelligence
ETFs
Economy
Want $10,000 in Passive Income? This Vanguard ETF Could Be Your Ticket to Making It Happen.
↗
December 18, 2025
Via
The Motley Fool
Topics
ETFs
Stocks
Is AbbVie a Millionaire Maker?
↗
December 18, 2025
Via
The Motley Fool
Topics
Intellectual Property
Worried About the Stock Market in 2026? These 3 Stocks Did Well During the Last Bear Market.
↗
December 18, 2025
Via
The Motley Fool
Topics
Intellectual Property
Stocks
The Yield Search: Why Retirees are Swapping Growth for Defense in a Shifting 2025 Market
December 18, 2025
Via
MarketMinute
Topics
Artificial Intelligence
Bonds
ETFs
Want Decades of Passive Income? Buy This ETF and Hold It Forever.
↗
December 17, 2025
Via
The Motley Fool
Topics
ETFs
Stocks
Novartis US Stock Rises On Reports Of White House Pricing Deal Due Friday — Roche Also In Talks
↗
December 17, 2025
Via
Stocktwits
Topics
Government
World Trade
Frequently Asked Questions
Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 229.31
When was AbbVie last traded?
The last trade of AbbVie was at 01/02/26 07:00 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.